AI-generated summary
The authors conducted a systematic review of controlled trials of photobiomodulation for pain in temporomandibular disorders, identifying nine reports covering eight cohorts. They report that pain decreased in most PBM groups, but placebo groups often improved comparably and between-group superiority was inconsistent. Certainty of evidence was low for myogenous and very low for arthrogenous disorders.
- Studies included
- 8
- Who or what was studied
- Adults with temporomandibular disorder-related pain diagnosed by RDC/TMD or DC/TMD criteria
- Wavelengths
- 635, 940 nm
- Limits stated in the abstract
- Protocols were heterogeneous, precluding quantitative synthesis, certainty was low to very low, and the joint-pain evidence rests on one small subgroup.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 635-940 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Systematic review, Laser, Digital object identifier, Low-level laser therapy, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.